Prevalence and risk factors of fatty liver in Portuguese adults-Reference-Cited by-同舟云学术

Prevalence and risk factors of fatty liver in Portuguese adults

Published:2020-05-19 Issue:6 Volume:50 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

Leitão Jorge¹²^ORCID,Carvalhana Sofia³,Cochicho Joana¹,Silva Ana Paula⁴^ORCID,Velasco Francisco⁵,Medeiros Isabel⁶^ORCID,Alves Ana Catarina⁷^ORCID,Bourbon Mafalda⁷^ORCID,Oliveiros Bárbara⁸^ORCID,Rodrigues Vitor⁹^ORCID,Sousa Rita¹⁰^ORCID,Sampaio Filipa¹⁰¹¹^ORCID,Carvalho Armando¹²^ORCID,Cortez‐Pinto Helena³¹²^ORCID

Affiliation:

1. Department of Internal Medicine Centro Hospitalar e Universitário de Coimbra Coimbra Portugal

2. Faculty of Medicine University of Coimbra Coimbra Portugal

3. Department of Gastroenterology Centro Hospitalar e Universitário Lisboa Norte Lisboa Portugal

4. Department of Gastroenterology Centro Hospitalar de Vila Nova de Gaia e Espinho Vila Nova de Gaia Portugal

5. Department of Gastroenterology Centro Hospitalar do Algarve, Hospital de Faro Faro Portugal

6. Department of Gastroenterology Hospital Espírito Santo Évora Portugal

7. Biosystems and Integrative Science Institute (BioISI) Instituto Nacional de Saúde Dr. Ricardo Jorge Lisboa Portugal

8. Laboratory of Biostatistics and Medical Informatics, Faculty of Medicine University of Coimbra Coimbra Portugal

9. Instituto de Higiene e Medicina Social Faculty of Medicine University of Coimbra Coimbra Portugal

10. Centro de Estudos de Medicina Baseada na Evidência Faculdade de Medicina Universidade de Lisboa Lisboa Portugal

11. Department of Public Health and Caring Sciences Uppsala University Uppsala Sweden

12. Clínica Universitária de Gastrenterologia Faculdade de Medicina Universidade de Lisboa Lisboa Portugal

Funder

Roche

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13235

Reference37 articles.

1. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

2. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

3. The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

4. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

5. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice;eBioMedicine;2023-07

2. The New FibroScan-AST (FAST) Score: Enhancing Diabetes Mellitus Impact on Metabolic-Associated Fatty Liver Disease;GE - Portuguese Journal of Gastroenterology;2022-10-24

3. Nonalcoholic Fatty Liver Disease: Current Global Burden;Seminars in Liver Disease;2022-05-26

4. The paradigm shift from NAFLD to MAFLD : A global primary care viewpoint;Liver International;2022-03-11

5. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis;Clinical Gastroenterology and Hepatology;2021-12